Alisa Lask

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
South Orange, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Alisa Lask
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Alisa Lask

Form 4 holding Director

NEPHROS INC

Security class
Common Stock
Shares / value
48,629
Estimated value
$109,167
Report date
01 Jan 2025
Price
$2.24
Ownership
Direct
Form 4 holding Director

RVL Pharmaceuticals plc

Security class
Ordinary Shares
Shares / value
112,557
Estimated value
$3,512
Report date
10 Aug 2023
Price
$0.0312
Ownership
Direct
Form 4 holding Director

NEPHROS INC

Security class
Stock Option (right to buy)
Shares / value
7,050
Estimated value
Report date
01 Jan 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,080

Insider Reports Filed by Alisa Lask

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .